![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, July 30, 2017 11:56:00 PM
The advantage with biosynthesis is mainly reduced time and cost.'
If one route of manufacturing produces a higher volume with less costs, how is the other method not inferior? I know it is not uncommon, but wouldn't cannabis variability make it more difficult than your average plant? The more variable the species = the more synthetics make the better route? Why are you even bothering Growing it considering the risks and GMP costs....
Targeted synthetics outperform the plant 10/10 times for that specific indication. Even if some of the 550ish compounds have a net positive effect, clearly it is not big enough to warrant smoking/edibles over a synthetic. And if they do have a benefit, that will be discovered and drugs improved one day.
Are cannabinoids via IV the best? The study I referenced would indicate not.....
'hough I'm skeptical that NB1111 will be successful because of tolerance'
Tolerance to what? The latest research said 1%< THC?
'"But if it's valued at a couple hundred million $$ then that's not bad for a few years work...".
Not bad at all, is that just a hypothetical figure or what you actually think it could be worth to Nemus? '
If the CINV market is 2b, and they can get 5% of that for a sustained period, you can do the math
Recent SKYE News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 01:27:39 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/20/2024 04:15:09 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/17/2024 08:27:44 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/10/2024 08:19:14 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/10/2024 08:17:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:02:13 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM